MedPath

THE EFFECT OF BEHAVIOURAL MODIFICATION THERAPY ON TOBACCO CESSATIO

Not Applicable
Completed
Registration Number
CTRI/2022/07/043815
Lead Sponsor
ARUMUGAM P M
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

•Participants who will give informed consent to participate in the study.

• Patients aged between 18 - 80yrs.

•Patients using tobacco for more than 6 months.

•A patient using tobacco for more than 3 times per day.

•No subjects should have undergone any behavioural counselling in the four-week period prior to the baseline examination.

Exclusion Criteria

•Participants who donâ??t give informed consent to participate in the study.

•Pregnant or lactating females.

•Patient undergoing nicotine replacement therapy.

•Those who are undergoing antibiotic or anti-inflammatory therapy or on medication for any underlying systemic disorders

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
reduction in the consumption a number of cigarettes smoked and smokeless tobaccoTimepoint: baseline, 10th day, 30th day, 3 months, 6 months.
Secondary Outcome Measures
NameTimeMethod
Assess the complete abstinence for any form of tobacco use for at least a monthTimepoint: after six months
© Copyright 2025. All Rights Reserved by MedPath